HCPCS drug code · CMS crosswalk
Breyanzi HCPCS Code
In short
Breyanzi is billed under HCPCS Q2054. One billing unit is up to 110 million car-positive viable t cells, per therapeutic dose. CMS's crosswalk lists 1 Breyanzi NDC under this code.
Reference
- Q2054
- HCPCS Level II drug codeBilling unit: up to 110 million car-positive viable t cells, per therapeutic dose
- Labelers
- Juno Therapeutics, Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Inflation-adjusted coinsurance. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Breyanzi units and claim line
Enter the dose given to get the Q2054 units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
Breyanzi NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 73153-0900-01 | Q2054 | Juno Therapeutics, Inc. | 1 | 1 |
Breyanzi: common questions
- What is the HCPCS code for Breyanzi?
- Breyanzi is billed under HCPCS Q2054. One billing unit is up to 110 million car-positive viable t cells, per therapeutic dose. CMS's crosswalk lists 1 Breyanzi NDC under this code.
- How many Q2054 billing units are in a package of Breyanzi?
- CMS lists 1 billing units per package, depending on the NDC, where one unit is up to 110 million car-positive viable t cells, per therapeutic dose. Units to report are based on the dose given, not the package.
- Is Q2054 a CPT code?
- No. Q2054 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.